# Copeptin in COVID-19

> **NCT05249751** · — · COMPLETED · sponsor: **Al-Azhar University** · enrollment: 160 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** Assessement of serum copeptin by ELISA technique

## Key facts

- **NCT ID:** NCT05249751
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-20
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-09-10
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2022-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05249751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05249751, "Copeptin in COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05249751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*